-
the germline variation characteristics of patients with hereditary diffuse gastric cancer in China!
Time of Update: 2023-02-03
Subsequently, Xu Ruihua's team compared the somatic variation burden of Chinese HDGC patients and TCGA sporadic diffuse gastric adenocarcinoma (D-STAD) patients, and found that the frequency of gene mutations in the two cohorts was significantly correlated (R=0.
-
for the treatment of relapsed/refractory diffuse large B-cell lymphoma in Hong Kong, China
Time of Update: 2023-02-03
On December 28, 2022, InnoCare (SSE: 688428; Hong Kong Stock Exchange code: 09969) today announced that tafasitamab in combination with lenalidomide has been approved by the Hong Kong Department of Health for the treatment of adult patients with relapsed/refractory diffuse large B-cell lymphoma (DLBCL) who are not eligible for autologous stem cell transplantation.
-
Blood Yuqin Song's team at Peking University discovered a potential new treatment for diffuse large B-cell lymphoma
Time of Update: 2023-02-01
iNatureIn the Phase 3 POLARIX study (NCT03274492), polatuzumab vedotin plus rituximab plus cyclophosphamide, doxorubicin, and prednisone (Pola-R-CHP) had a similar safety profile in previously untreat
-
Frameless robot-guided stereotactic biopsy for the diagnosis of diffuse endogenous pontine glioma in children
Time of Update: 2023-01-06
[Epub ahead of print] 】 Research background Diffuse endogenous pontine glioma (DIPG) in children has a deep location, special location, high surgical risk, and is prone to serious complications after surgery, with an average survival of less than 1 year.
-
Frameless robot-guided stereotactic biopsy for the diagnosis of diffuse endogenous pontine glioma in children
Time of Update: 2023-01-06
[Epub ahead of print] 】 Research background Diffuse endogenous pontine glioma (DIPG) in children has a deep location, special location, high surgical risk, and is prone to serious complications after surgery, with an average survival of less than 1 year.
-
and refractory diffuse large B-cell lymphoma? The 7th International Summit Forum on Anti-Leukemia and Lymphoma
Time of Update: 2023-01-06
CAR-TCAR-T is an effective option for patients with R/R DLLBL who have failed R-CHOP, are not suitable for transplantation, or have failed HDC-ASCT 。 Current CD19-targeting CAR-T cell products for DLBCL include Axicabtagene ciloleucel (Axi-cel, ZUMA-1 study), Tisagenlecleucel (Tisa-cel, JULIET study), and Lisocabtagene maraleucel (Liso-cel, TRANSCEND study), at R/R Higher treatment was shown in all third-line and above treatments for DLBCL: ORR of 52-83% and CR rate of 40% to 58%.
-
and refractory diffuse large B-cell lymphoma? The 7th International Summit Forum on Anti-Leukemia and Lymphoma
Time of Update: 2023-01-06
CAR-TCAR-T is an effective option for patients with R/R DLLBL who have failed R-CHOP, are not suitable for transplantation, or have failed HDC-ASCT 。 Current CD19-targeting CAR-T cell products for DLBCL include Axicabtagene ciloleucel (Axi-cel, ZUMA-1 study), Tisagenlecleucel (Tisa-cel, JULIET study), and Lisocabtagene maraleucel (Liso-cel, TRANSCEND study), at R/R Higher treatment was shown in all third-line and above treatments for DLBCL: ORR of 52-83% and CR rate of 40% to 58%.
-
major milestone - FDA orphan drug certification for diffuse midline glioma DMG
Time of Update: 2023-01-06
ACT001 is currently one of the few immunomodulators in the world that can cross the blood-brain barrier, and drug research and development focuses on brain tumors and brain inflammation, and has been approved for 12 clinical trials in China, the United States and Australia, including 4 phase 1 clinical trials, 7 1b/2a or phase 2 clinical trials, and 1 2b/3 phase clinic.
-
major milestone - FDA orphan drug certification for diffuse midline glioma DMG
Time of Update: 2023-01-06
ACT001 is currently one of the few immunomodulators in the world that can cross the blood-brain barrier, and drug research and development focuses on brain tumors and brain inflammation, and has been approved for 12 clinical trials in China, the United States and Australia, including 4 phase 1 clinical trials, 7 1b/2a or phase 2 clinical trials, and 1 2b/3 phase clinic.
-
index and clinical features of diabetic diffuse neuropathy
Time of Update: 2022-12-04
Jianjun Liu from the Shenzhen Center for Disease Control and Prevention in China and Yan Wu from Shenzhen People's Hospital tested the hypothesis that protein pyrrole adducts are associated with elevated glycemic index and some clinical features in diabetic diffuse neuropathy.
-
European Radiology: How valuable is breast MR diffusion-weighted imaging?
Time of Update: 2022-11-25
5T and 3T scanners or only 3T scanners and their willingness to join the scanner working groupIn summary, the data presented in this study can better understand the role and value of DWI in breast clinical MRI, and provide a reference for its standardization and implementation.
-
The world's first commercial graphene-reinforced fiber composite swimming pool comes out, which can reduce the water diffusion coefficient by 10 times
Time of Update: 2022-11-17
The graphene nanotechnology swimming pool obtained by using graphene-modified resin combined with conventional GFRP fabrication is lighter, stronger and more durable than conventional GFRP pools, the company said .
-
The world's first commercial graphene-reinforced fiber composite swimming pool comes out, which can reduce the water diffusion coefficient by 10 times
Time of Update: 2022-11-17
The graphene nanotechnology swimming pool obtained by using graphene-modified resin combined with conventional GFRP fabrication is lighter, stronger and more durable than conventional GFRP pools, the company said .
-
European Radiology: imaging-based risk stratification enables prognostic assessment at the molecular level of diffuse glioma tissue
Time of Update: 2022-11-14
ROC curves of 1, 2, 3 and 5 years after surgery are providedIn this study, imaging-based risk stratification achieves a prognostic prediction of diffuse gliomas (NOS) at the tissue molecular level.
-
How is diffuse gray matter zotisis diagnosed?
Time of Update: 2022-11-14
Ectopic large clumps of gray matter are often connected to the gray matter of the normal cortex, often with mass effects, such as compression of the ventricles.